Skip to main content
PNTG
NASDAQ Life Sciences

Pennant Group Posts $302.3M in Q3 Revenue, Topping Last Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$44.04
Mkt Cap
$1.538B
52W Low
$22.255
52W High
$44.239
52W Position info
98% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

PNTG sits 98% above its 52-week low of $22.255.

Summary

Pennant Group reported third-quarter revenue of $302.3M, up from $298M in Q2 2026, which itself grew 35.8% year-over-year. The sequential gain extends a steep growth run driven by home health and hospice, with acquisitions and rising debt funding the expansion. Third-quarter net income was $9.6M, up 58.5%, with adjusted EBITDA of $24.7M, up 42.4%, and GAAP diluted EPS of $0.26. Adjusted EPS came in at 35c, which fell short of the IBES estimate of USD 0.36. The stock sits near its 52-week high of $44.24, so the bar for this print was high.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Pennant's Q3 net income was $9.6M, up 58.5%, with adjusted EBITDA of $24.7M, up 42.4%, and GAAP diluted EPS of $0.26.

At the time of this announcement, PNTG was trading at $44.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $22.26 to $44.24. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PNTG - Latest Insights

PNTG
Nov 04, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
PNTG
Nov 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
PNTG
Sep 16, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
PNTG
Aug 05, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
PNTG
Aug 04, 2026, 4:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7